GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Titan Medical Inc (OTCPK:TMDIF) » Definitions » LT-Debt-to-Total-Asset

TMDIF (Titan Medical) LT-Debt-to-Total-Asset : 0.13 (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Titan Medical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Titan Medical's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.13.

Titan Medical's long-term debt to total assets ratio increased from Jun. 2023 (0.09) to Jun. 2024 (0.13). It may suggest that Titan Medical is progressively becoming more dependent on debt to grow their business.


Titan Medical LT-Debt-to-Total-Asset Historical Data

The historical data trend for Titan Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Medical LT-Debt-to-Total-Asset Chart

Titan Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.03 0.02 0.19 0.10

Titan Medical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.10 0.10 0.11 0.13

Titan Medical LT-Debt-to-Total-Asset Calculation

Titan Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=0.856/8.762
=0.10

Titan Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )/Total Assets (Q: Jun. 2024 )
=0.595/4.514
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Titan Medical  (OTCPK:TMDIF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Titan Medical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Titan Medical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Medical Business Description

Traded in Other Exchanges
N/A
Address
76 Berkeley Street, Toronto, ON, CAN, M5A 2W7
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.

Titan Medical Headlines

From GuruFocus

Titan Medical Announces Commencement of Strategic Review Process

By Value_Insider Value_Insider 11-30-2022

Q1 2022 Titan Medical Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Titan Medical Reports Fiscal Year 2023 Results

By GlobeNewswire 03-29-2024

Titan Medical Provides Corporate Update

By Stock market mentor Stock market mentor 02-08-2023

Q4 2021 Titan Medical Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2021 Titan Medical Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024